PerkinElmer Slowly Building MDx Profile | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – With this week's announcement of its acquisition of nucleic acid isolation technology firm Chemagen Biopolymer-Technologie, PerkinElmer is taking another step toward building out is molecular diagnostics portfolio.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.